HomeAI · summaries
Storia in 11 fonti
Opinion | A desperately needed reset at the FDA
What Marty Makary's successor can learn from his mistakes.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
biopharmadive.com
FDA chief Marty Makary resigns from agency, ending tumultuous tenure
Makary’s exit ends a turbulent run marred by leadership upheaval, mass layoffs, political pressure and public spats with drugmakers.
- ·
apnews.com
Trump's FDA chief is out after angering pharma CEOs, vaping lobbyists and anti-abortion activists
Marty Makary is resigning as President Donald Trump's Food and Drug Administration chief. The surgeon and health researcher's tenure had drawn complaints from pharmaceutical…
- ·
statnews.com
Makary departs FDA amid turmoil as Diamantas, agency's top food official, steps in
Food and Drug Administration Commissioner Marty Makary is resigning from his role after a tumultuous tenure.
- ·
axios.com
Marty Makary out as FDA chief
His tenure was marked by organizational upheaval, controversies over drug approvals and tensions with the White House.
- ·
huffpost.com
Trump FDA Chief Is Leaving After Angering Pharma CEOs, Vaping Lobbyists And Anti-Abortion Groups
Marty Makary is resigning after just over a year leading the powerful health regulatory agency.
- ·
politico.com
Makary’s time atop FDA over, Diamantas named acting commissioner
The gastrointestinal surgeon’s tenure was marked by mass layoffs, persistent churn among senior leaders and policy fights.
- ·
usatoday.com
FDA Commissioner Marty Makary resigns after pressure campaign
FDA Commissioner Marty Makary resigned, President Donald Trump said, marking the latest high-profile leadership shakeup at HHS.
- ·
Why Marty Makary was the worst FDA commissioner in 25 years
Marty Makary, who resigned under pressure from the FDA, brought to the job a fundamental lack of understanding of the nature of the role, STAT's Matthew Herper writes.
- ·
FDA’s leadership void leaves biotech with renewed ‘uncertainty’
Marty Makary's resignation leaves the agency with temporary directors in three top positions, and a number of newly instituted policies with an unclear future.
- ·
endpoints.news
Post-Hoc: What brought down the FDA commissioner
Marty Makary resigned as FDA commissioner Tuesday. The next commissioner will inherit the same punishing contradictions, and a weaker, politicized agency.
- ·
washingtonpost.com
Opinion | A desperately needed reset at the FDA
What Marty Makary's successor can learn from his mistakes.
- ·
medpagetoday.com
Here's What Stakeholders Want From the Next FDA Commissioner
Marty Makary is out, and experts are calling for a return to order
- ·
thedispatch.com
Marty Makary’s Turbulent Tenure at FDA Comes to an End
Brought in as an agency critic, the commissioner drew fire from drug developers and abortion foes.
- ·
Post-Hoc Live: Marty Makary's FDA downfall and legacy
Endpoints News and Financial Times journalists discuss the downfall of FDA Commissioner Marty Makary, live in New York at the FT's biotech and pharma summit.